SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on November 1, 2023. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The report addresses "Other Events" occurring on the filing date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
On November 1, 2023, the U.S. Patent and Trademark Office awarded several new utility patents to BioSig Technologies, Inc. This event was announced via a press release attached as Exhibit 99.1.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure of the patent awards. No unusual items or contingencies were disclosed in this report.
Investor Verification Checklist
- Verify the specific details and scope of the new utility patents by reviewing the attached press release (Exhibit 99.1).
- Confirm the commercial applicability of the awarded patents to the company's current product pipeline.
- Check subsequent filings for any financial impact or revenue recognition related to these intellectual property assets.